Trial Profile
A Retrospective, Longitudinal study to compare the safety of Perampanel and Lacosamide associated with long-term cognitive and behavioral side effects in an outpatient setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 12 Oct 2018 New trial record